Kühn et al. [139] explained the phenomenon of HOX and FLT3 gene upregulation in NPM1-mutated AML as a result of the activity of chromatin regulators, KMT2A and DOT1L. The gene discussed is DOT1L; the disease is acute myeloid leukemia.